Lv1
48 积分 2024-05-03 加入
S2711 Efficacy of Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in the Treatment of Primary Biliary Cholangitis: A Meta-Analysis of Randomized Controlled Trials
8天前
已完结
The PPARα–leukotriene B4 pathway to inflammation control
13天前
已完结
Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR)
13天前
已完结
Discovery of a Potent, Selective, and Multiple His435 Mutation-Sensitive Thyroid Hormone Receptor β Agonist
18天前
已完结
A new liver-targeted agonist of thyroid hormone receptor beta resmetirom in treating MASLD/MASH: from mechanism to therapy
26天前
已关闭
A new liver-targeted agonist of thyroid hormone receptor beta resmetirom in treating MASLD/MASH: from mechanism to therapy
28天前
已关闭
USP2 promotes metabolic dysfunction-associated steatotic liver disease progression via stabilization of PPARγ
2个月前
已完结
Leptin-specific mechanisms for impaired liver regeneration in ob/ob mice after toxic injury
2个月前
已完结
The deubiquitinase USP28 maintains the expression of PPARγ and its inactivation protects mice from diet-induced MASH and hepatocarcinoma
2个月前
已完结
A novel heterodimerization partner for thyroid hormone receptor. Peroxisome proliferator-activated receptor
2个月前
已关闭
皖公网安备34019202002308
